Press release
Global Ocular Drug Delivery Market Growth Prospects, Future Industry Landscape 2033 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc
Ocular Drug Delivery Global Market Report 2024
The Business Research Company offers in-depth market insights through Ocular Drug Delivery Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The ocular drug delivery market size has grown strongly in recent years. It will grow from $17.39 billion in 2023 to $18.64 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rise in ocular diseases, aging population trends, advancements in pharmaceutical formulations, clinical advancements in ophthalmology, prevalence of diabetes-related eye conditions..
The ocular drug delivery market size is expected to see strong growth in the next few years. It will grow to $24.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising incidence of age-related eye diseases, focus on personalized medicine in ophthalmology, increased investment in ophthalmic research, demand for prolonged drug release, global initiatives for eye health.. Major trends in the forecast period include integration of smart drug delivery devices, personalized medicine in ocular drug formulations, development of topical ophthalmic therapies, collaborations for cross-industry innovations..
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=11901&type=smp
Market Segmentation:
The ocular drug delivery market covered in this report is segmented -
1) By Technology: Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, Other Technologies
2) By Formulation: Liposomes And Nanoparticles, Solution, Emulsion, Suspension, Ointment
3) By Disease: Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, Other Diseases
4) By End User: Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers
Major Driver - Rising Prevalence Of Eye Disorders Boosts Ocular Drug Delivery Market
An increase in the prevalence of eye disorders is expected to propel the growth of the ocular drug delivery market going forward. Eye disorders refer to a wide range of conditions that affect the eyes, vision, or the structures surrounding the eyes. Ocular drug delivery allocates medications directly to the target site, providing greater drug concentrations at the targeted area, optimizing therapeutic efficacy while avoiding systemic adverse effects, and improving eye disorders. For instance, in March 2023, according to the World Health Organization, a Switzerland-based United Nations agency, globally, 2.2 billion people will have a near- or far-sighted impairment. According to estimates, cataracts (94 million) and uncorrected refractive problems (88.4 million) are the main causes of visual loss or impaired vision. In addition, glaucoma (7.7 million cases), corneal opacities (4.2 million cases), diabetic retinopathy (3.9 million cases), and trachoma (2 million cases) are the other common causes of vision loss. Therefore, the increase in the prevalence of eye disorders is driving the growth of the ocular drug delivery market.
Competitive Landscape:
Major companies operating in the ocular drug delivery market report are Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Akorn Inc., Valeant Pharmaceuticals International Inc., Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., Ophthotech Corporation, Acucela Inc., Graybug Vision Inc., Amakem NV, Kala Pharmaceuticals Inc., Icon Bioscience Inc., Clearside Biomedical Inc., Aerpio Therapeutics Inc., Senju Pharmaceutical Co. Ltd., Shire plc, Spark Therapeutics Inc., Sucampo Pharmaceuticals Inc., Carl Zeiss Meditec AG, EyeGate Pharmaceuticals Inc.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/ocular-drug-delivery-global-market-report
Top Trend - Pioneering Product Innovations In The Ocular Drug Delivery Market
Product innovation is a key trend gaining popularity in the ocular drug delivery market. Companies operating in the ocular drug delivery market are focused on developing new product innovations to sustain their position in the market. For instance, in March 2023, Alcon AG, a Swiss pharmaceutical and medical device firm focusing on eye care products, launched TOTAL30 for astigmatism and SYSTANE HYDRATION for dry eye and ocular health. TOTAL30 is the debut and only Toric lens to combine water Gradient and Celligent Technology, allowing the lens that mimics the structure of the ocular surface and provides superior performance in areas like comfort, stability, and visual acuity. SYSTANE HYDRATION PF is an ocular health eye drop that uses HydroBoost technology to restore moisture, prevent irritation, and give relief from dry eye symptoms.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Ocular Drug Delivery Market Characteristics
3. Ocular Drug Delivery Market Trends And Strategies
4. Ocular Drug Delivery Market - Macro Economic Scenario
5. Ocular Drug Delivery Market Size And Growth
…..
27. Ocular Drug Delivery Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ocular Drug Delivery Market Growth Prospects, Future Industry Landscape 2033 | Pfizer Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Allergan Inc., Regeneron Pharmaceuticals Inc here
News-ID: 3429734 • Views: …
More Releases from The Business Research Company
Camera Modules Market Report 2024-2033: Size, Share, Growth, Trends, Analysis, F …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Camera Modules Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $78.45 billion In 2028 At…
Boron Market Report 2024-2033: Size, Growth, Trends, Analysis, Demand, Key Playe …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Boron Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $12.68 billion In 2028 At A…
Bioethanol Yeast Market Report 2024-2033: Size, Share, Growth, Trends, Analysis, …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Bioethanol Yeast Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $33.99 billion In 2028 At…
Baby Wipes Market Report 2024-2033: Size, Growth, Trends, Analysis, Demand, Key …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Baby Wipes Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $7.85 billion In 2028 At…
More Releases for Ocular
Developments in Gene Therapy for Ocular Diseases
The Ophthalmic drugs industry continues to expand year on year, with an ageing population there is continual demand for advancements in ophthalmic treatments. This year's Ophthalmic Drugs Conference will have a key focus on gene therapy and artificial intelligence with developments on the latest drug pipelines and clinical trials.
The conference will convene on 21 - 22 November 2022 in London, UK, this year attendees will hear from industry giants about…
Advancement In Ocular Surgery And New Launches Of Ocular Devices Are Expected To …
The Global Ocular Surgery Market, by device type (Cataract surgery devices, Glaucoma surgery devices, and Vitrectomy surgery devices) and region was valued at US$ 1,517.5 million in 2017 and is projected to exhibit a CAGR of 7.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Growing aging population and high incidence rate of diabetes coupled with technological advancement are drivers fueling growth…
Global Ocular Drug Delivery Technology Market 2017 – 2025 : Attractiveness, An …
Researchmoz added Most up-to-date research on "Ocular Drug Delivery Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its huge collection of research reports.
Ocular Drug Delivery Technology Market: Overview
This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in…
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape.
Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor…
Ocular Drug Delivery Technology Market grows with increasing preference among pa …
Global Ocular Drug Delivery Technology Market: Overview
The top three players in the global ocular drug delivery technology market hold more than 50.0% share in it. This makes the competitive landscape consolidated. The topnotch players have climbed to the top owing to their broad range of topical ocular drug products.
A noticeable trend in the global ocular drug delivery technology market is the small and large regional players collaborating with…
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape.
Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include…
